Revisiting the metabolic syndrome.

Area of Science:

• Cardiology
• Endocrinology
• Public Health

Background:

• Metabolic syndrome (MS) is a cluster of cardiometabolic risk factors, including abdominal obesity, hyperglycemia, dyslipidemia, and elevated blood pressure, often linked to insulin resistance.
• MS is prevalent, affecting 25-33% of adults, with rising rates paralleling increasing obesity and population aging.
• It is associated with a significantly increased risk of cardiovascular disease and type 2 diabetes.

Purpose of the Study:

• To review the definition, prevalence, and clinical implications of metabolic syndrome (MS).
• To highlight the role of MS in cardiovascular risk assessment and its relationship with insulin resistance.
• To emphasize the importance of lifestyle interventions in managing MS and reducing associated health risks.

Main Methods:

• Review of operational definitions of MS proposed by major health organizations (WHO, NCEP, IDF).
• Analysis of the association between MS components and increased risk of cardiovascular disease and type 2 diabetes.
• Discussion of current guidelines for cardiovascular risk assessment and management of MS.

Main Results:

• MS definition has evolved, with recent emphasis on central adiposity.
• MS serves as a clinically useful framework for identifying individuals at increased long-term risk.
• Lifestyle interventions (diet, exercise, weight reduction) are crucial for managing MS.

Conclusions:

• Metabolic syndrome (MS) is a critical indicator of long-term health risks, including cardiovascular disease and type 2 diabetes.
• Early identification and management of MS through lifestyle modifications are essential for public health.
• MS assessment should complement traditional cardiovascular risk factor evaluation for comprehensive patient care.